China Regenerative Medicine International (8158) Stock Overview

China Regenerative Medicine International Limited, an investment holding company, engages in the production and sale of healthcare products and services in Hong Kong and the People's Republic of China. The company offers various health management services, such as assessment of health situation, treatment for detox, balance of inner body, nourishing organs, and enhancement of immune system; and beauty services, including non-surgical medical aesthetic services, basic skincare, solutions for youthful skin, hair revitalizing, lines firming, partial remodelling, and intimate rejuvenation treatment services. The company was formerly known as China Bio-Med Regeneration Technology Limited and changed its name to China Regenerative Medicine International Limited in March 2015. China Regenerative Medicine International Limited was founded in 1995 and is headquartered in Tsim Sha Tsui, Hong Kong.